B

AstraZeneca PLC AZN

$178.76 -$3.51-1.93% NYSE
Recommendation
Dividend Power Score
Day's Range
$178.29$181.50
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

AZN Rating

Reward
Risk

AZN Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

AZN Company Overview

AstraZeneca PLC is a global biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of prescription medicines. The company operates primarily in the industries of oncology, rare diseases, cardiovascular, renal and metabolism, respiratory and immunology, vaccines, and infectious diseases. AstraZeneca generates revenue through sales of branded pharmaceutical products, strategic collaborations, licensing agreements, and research partnerships. Its largest revenue drivers have included oncology therapies such as Tagrisso, Imfinzi, Lynparza, and Enhertu, alongside medicines in cardiovascular and rare disease categories.

The company serves healthcare providers, hospitals, governments, and patients across both developed and emerging markets. AstraZeneca is recognized for its strong oncology pipeline, extensive biologics capabilities, and integration of advanced scientific platforms including antibody-drug conjugates, cell therapies, and precision medicine technologies. AstraZeneca was formed in 1999 through the merger of Sweden-based Astra AB and the UK-based Zeneca Group. The company expanded significantly through acquisitions including MedImmune, Alexion Pharmaceuticals, and partnerships with biotechnology firms and academic institutions, helping evolve it into one of the world’s largest research-driven pharmaceutical companies.

Data compiled by narrative technology. May contain errors.
Sector
--
Industry
--

AZN Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

AZN Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

AZN Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

AZN Price History

Loading...
52-Week Range43% of range
Current
$178.76
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

AZN Valuation

Market Cap
Market Cap Rank
#63
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

AZN Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

AZN Corporate Info

Phone Number
44 20 3749 5000
Address
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge, CB2 0AA
Country
Year Founded

AZN Filings

Filing Date
Friday, October 30, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 22 and 26 (est)

AZN Headlines

11/16/2026 - Pharmaceutical Business Review